Literature DB >> 20153980

Shaping of iNKT cell repertoire after unrelated cord blood transplantation.

Vivien Beziat1, Stéphanie Nguyen, Mark Exley, Abla Achour, Tabassonne Simon, Patrice Chevallier, Anne Sirvent, Stéphane Vigouroux, Patrice Debré, Bernard Rio, Vincent Vieillard.   

Abstract

Invariant natural killer T (iNKT) cells have a pivotal role in immune regulation, tumor surveillance, and the induction of allograft tolerance. In this report, we analyze the recovery of iNKT cells after unrelated cord blood transplantation (UCBT) of adult patients with high-risk acute myeloid leukemia. We found that iNKT cells were reconstituted within 1 month after UCBT, at the same time as NK cells and before conventional T cells. These iNKT cells displayed a unique primed/central memory CD4(+)CD45RO(+)CCR7(+)CD62L(+) phenotype soon after the transplant. Interestingly, the functional competence of these cells was poor, except for their high GM-CSF production capacity. However, this post-graft functionally immature state was transient and all of the patients tested had fully functional iNKT cells 3 to 6 months post-UCBT and high cytolytic capacity for destroying primary CD1d(+) myeloid blast cells. Our results raise the possibility that iNKT cells might play a key role in graft-versus-leukemia activity after UCBT. Copyright 2008 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20153980     DOI: 10.1016/j.clim.2010.01.010

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  11 in total

1.  Pre-transplant donor CD4- invariant NKT cell expansion capacity predicts the occurrence of acute graft-versus-host disease.

Authors:  M-T Rubio; M Bouillié; N Bouazza; T Coman; H Trebeden-Nègre; A Gomez; F Suarez; D Sibon; A Brignier; E Paubelle; S Nguyen-Khoc; M Cavazzana; O Lantz; M Mohty; S Urien; O Hermine
Journal:  Leukemia       Date:  2016-10-14       Impact factor: 11.528

2.  Development of Hematopoietic Stem Cell-Engineered Invariant Natural Killer T Cell Therapy for Cancer.

Authors:  Yanni Zhu; Drake J Smith; Yang Zhou; Yan-Ruide Li; Jiaji Yu; Derek Lee; Yu-Chen Wang; Stefano Di Biase; Xi Wang; Christian Hardoy; Josh Ku; Tasha Tsao; Levina J Lin; Alexander T Pham; Heesung Moon; Jami McLaughlin; Donghui Cheng; Roger P Hollis; Beatriz Campo-Fernandez; Fabrizia Urbinati; Liu Wei; Larry Pang; Valerie Rezek; Beata Berent-Maoz; Mignonette H Macabali; David Gjertson; Xiaoyan Wang; Zoran Galic; Scott G Kitchen; Dong Sung An; Siwen Hu-Lieskovan; Paula J Kaplan-Lefko; Satiro N De Oliveira; Christopher S Seet; Sarah M Larson; Stephen J Forman; James R Heath; Jerome A Zack; Gay M Crooks; Caius G Radu; Antoni Ribas; Donald B Kohn; Owen N Witte; Lili Yang
Journal:  Cell Stem Cell       Date:  2019-09-05       Impact factor: 24.633

3.  Human CD4- invariant NKT lymphocytes regulate graft versus host disease.

Authors:  Tereza Coman; Julien Rossignol; Maud D'Aveni; Bettina Fabiani; Michael Dussiot; Rachel Rignault; Joel Babdor; Marie Bouillé; André Herbelin; Francine Coté; Ivan C Moura; Olivier Hermine; Marie-Thérèse Rubio
Journal:  Oncoimmunology       Date:  2018-08-23       Impact factor: 8.110

4.  Invariant natural killer T cells developing in the human fetus accumulate and mature in the small intestine.

Authors:  L Loh; M A Ivarsson; J Michaëlsson; J K Sandberg; D F Nixon
Journal:  Mucosal Immunol       Date:  2014-03-19       Impact factor: 7.313

Review 5.  Invariant natural killer T cells in hematopoietic stem cell transplantation: killer choice for natural suppression.

Authors:  P Guan; H Bassiri; N P Patel; K E Nichols; R Das
Journal:  Bone Marrow Transplant       Date:  2016-02-15       Impact factor: 5.174

Review 6.  Ontogeny of Innate T Lymphocytes - Some Innate Lymphocytes are More Innate than Others.

Authors:  David Vermijlen; Immo Prinz
Journal:  Front Immunol       Date:  2014-10-10       Impact factor: 7.561

Review 7.  Invariant Natural Killer T Cells As Suppressors of Graft-versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Melissa Mavers; Kristina Maas-Bauer; Robert S Negrin
Journal:  Front Immunol       Date:  2017-07-31       Impact factor: 7.561

8.  iNKT cells coordinate immune pathways to enable engraftment in nonconditioned hosts.

Authors:  Nicholas J Hess; Nikhila S Bharadwaj; Elizabeth A Bobeck; Courtney E McDougal; Shidong Ma; John-Demian Sauer; Amy W Hudson; Jenny E Gumperz
Journal:  Life Sci Alliance       Date:  2021-06-10

9.  A humanized monoclonal antibody specific for invariant Natural Killer T (iNKT) cells for in vivo depletion.

Authors:  Felix Scheuplein; Abraham Thariath; Susan Macdonald; Alemseged Truneh; Robert Mashal; Robert Schaub
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240

10.  Predictive Role of Circulating Immune Cell Subtypes Early after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Leukemia.

Authors:  Tae Woo Kim; Sung-Soo Park; Ji-Young Lim; Gi June Min; Silvia Park; Young-Woo Jeon; Seung-Ah Yahng; Seung-Hwan Shin; Sung-Eun Lee; Jae-Ho Yoon; Byung-Sik Cho; Ki-Seong Eom; Seok Lee; Hee-Je Kim; Chang-Ki Min
Journal:  Int J Stem Cells       Date:  2018-12-31       Impact factor: 2.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.